- Federal agenciesImproved federal data collection from qCDSMs could enable more accurate measurement of ordering behavior and imaging ut…
- Potential benefitExemptions for clinical trials, small and rural practices, and certain screening services may reduce compliance burden…
- Potential benefitRequiring the ordering professional NPI on claims and clearer reporting paths may increase accountability and make foll…
ROOT Act
Referred to the Committee on Energy and Commerce, and in addition to the Committee on Ways and Means, for a period to be subsequently determined by the Speaker, in each case for c…
This bill (ROOT Act) amends Medicare rules (section 1834(q) of the Social Security Act) governing appropriate use criteria (AUC) and qualified clinical decision support mechanisms (CDSMs) for certain outpatient imaging. Effective January 1, 2026, it requires CDSMs to report specified data to the Secretary of HHS, requires the furnishing professional to include the ordering professional’s NPI on claims, and creates exemptions (clinical trials, small practices of 15 or fewer ordering professionals, practices in rural Health Professional Shortage Areas, and certain screening/preventive imaging such as mammography and CT lung screening).
Whether expanded data reporting and NPI requirements are a necessary quality-control measure (liberal/centrist) or an undue federal burden and overreach (conservative).
Relative to its intended legislative type, this bill is a clear statutory amendment that specifies new data collection, reporting, and compliance measurement requirements for appropriate use criteria of applicable imaging services.
This bill (ROOT Act) amends Medicare rules (section 1834(q) of the Social Security Act) governing appropriate use criteria (AUC) and qualified clinical decision support mechanisms (CDSMs) for certain outpatient imaging.
Effective January 1, 2026, it requires CDSMs to report specified data to the Secretary of HHS, requires the furnishing professional to include the ordering professional’s NPI on claims, and creates exemptions (clinical trials, small practices of 15 or fewer ordering professionals, practices in rural Health Professional Shortage Areas, and certain screening/preventive imaging such as mammography and CT lung screening).
The Secretary is directed to set reporting and compliance requirements, define low-compliant ordering professionals based on a compliance rate using CDSM data, and conduct a study with a report to Congress by January 1, 2031 (and every 5 years thereafter) on compliance and utilization and potential remedies (including prior authorization or payment adjustments).
On content alone, the bill is a focused administrative modification to an existing Medicare program and contains compromise elements (exemptions, phased start, study requirement), which increase its practical prospects. However, it imposes new reporting requirements and creates a clearer pathway for future enforcement actions that could draw stakeholder opposition; it does not include obvious high-cost spending or popular giveaways that would accelerate rapid enactment. Passage is plausible if folded into a larger Medicare or regulatory package or if stakeholder concerns are mitigated, but as a standalone measure it faces moderate resistance.
Relative to its intended legislative type, this bill is a clear statutory amendment that specifies new data collection, reporting, and compliance measurement requirements for appropriate use criteria of applicable imaging services. It enumerates exemptions, prescribes an effective date, and defines a compliance-rate methodology while delegating implementation details to the Secretary.
Whether expanded data reporting and NPI requirements are a necessary quality-control measure (liberal/centrist) or an undue federal burden and overreach (conservative).
Who stands to gain, and who may push back.
These are examples from the analysis, not a ranked list of the most-affected groups.
- Potential burdenMandating qCDSM reporting to the Secretary and adding NPI requirements on claims increases administrative and IT burden…
- Local governmentsIf the Secretary uses compliance data to impose prior authorization, payment adjustments, or other sanctions on designa…
- Potential burdenReliance on qCDSM-reported data to calculate compliance may produce incomplete or biased compliance measures if not all…
Why the argument around this bill splits.
Whether expanded data reporting and NPI requirements are a necessary quality-control measure (liberal/centrist) or an undue federal burden and overreach (conservative).
A mainstream progressive would likely read this as a federal effort to improve clinical oversight of imaging, reduce unnecessary procedures, and gather data to inform policy.
They would appreciate the explicit exemptions for small and rural practices and for common screening tests that protect access to preventive care.
They would also be cautious about the bill enabling future use of prior authorization or payment penalties against 'low-compliant' clinicians and would want safeguards to ensure equity, privacy, and that administrative burden does not harm underserved communities.
A moderate/centrist would view the bill as a pragmatic, evidence-building approach: it strengthens data collection and accountability for imaging orders while adding targeted exemptions for small/rural providers and important screening tests.
They would welcome the mandated study and periodic reporting to Congress before harsh penalties are implemented, but want clarity about administrative costs, timeline, and rulemaking.
They will judge it on how the Secretary defines compliance thresholds and implements reporting with minimal disruption to patient care and provider workflows.
A mainstream conservative would likely be skeptical of expanded federal data collection and reporting mandates, viewing them as added administrative burden and federal overreach into medical practice.
They would welcome the exemptions for small practices and screening tests, but worry those exceptions are limited and that the bill lays groundwork for further mandates such as prior authorization or payment reductions.
Privacy, cost, and the expansion of CMS rulemaking authority would be primary concerns; they would prefer less prescriptive federal involvement and stronger limits on use of the data.
The path through Congress.
Reached or meaningfully advanced
Reached or meaningfully advanced
Still ahead
Still ahead
Still ahead
On content alone, the bill is a focused administrative modification to an existing Medicare program and contains compromise elements (exemptions, phased start, study requirement), which increase its practical prospects. However, it imposes new reporting requirements and creates a clearer pathway for future enforcement actions that could draw stakeholder opposition; it does not include obvious high-cost spending or popular giveaways that would accelerate rapid enactment. Passage is plausible if folded into a larger Medicare or regulatory package or if stakeholder concerns are mitigated, but as a standalone measure it faces moderate resistance.
- No cost estimate or CBO score is provided in the text; fiscal implications for providers, CDSMs, and CMS implementation are therefore unknown.
- Stakeholder positions (physician specialty societies, CDSM vendors, payer groups, rural health advocates) are not stated; their support or opposition will strongly affect legislative momentum.
Recent votes on the bill.
No vote history yet
The bill has not accumulated any surfaced votes yet.
Go deeper than the headline read.
Whether expanded data reporting and NPI requirements are a necessary quality-control measure (liberal/centrist) or an undue federal burden…
On content alone, the bill is a focused administrative modification to an existing Medicare program and contains compromise elements (exemp…
Relative to its intended legislative type, this bill is a clear statutory amendment that specifies new data collection, reporting, and compliance measurement requirements for appropriate use criteria of applicable imagi…
Go beyond the headline summary with full stakeholder mapping, legislative design analysis, passage barriers, and lens-by-lens tradeoff breakdowns.